SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
化学名称: Cis-4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol hydrochloride (as per EP)
异名: Cis-Ambroxol HCl
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
微笑: BrC1=CC(Br)=C(N)C(CN[C@H]2CC[C@@H](O)CC2)=C1.Cl
Ambroxol EP Impurity D is chemically Cis-4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol hydrochloride (as per EP). It is also known as Cis-Ambroxol HCl . Ambroxol EP Impurity D is supplied with detailed characterization data compliant with regulatory guideline. Ambroxol EP Impurity D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ambroxol .
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Development and validation of a stability-indicating LC method for simultaneous determination of related compounds of guaifenesin, terbutaline sulfate and ambroxol HCl in cough syrup formulation
K. Lakshmi Narasimha Rao a,b, Ch. Krishnaiah a , K. Sudheer Babu a , K. Padmaja Reddy
Journal of Saudi Chemical Society 18(5):593-600
Isolation, Identification, and Characterization of One Degradation Product in Ambroxol by HPLC-Hyphenated Techniques
Veera Raghava Raju Thummala , Mrutyunjaya Rao Ivaturi , Someswara Rao Nittala
Sci Pharm. 2014; 82: 247–263
Development and Validation of RP-HPLC Method for Simultaneous Determination of Guaifenesin Impurities in Multi Drug Combinations
By Levon A. Melikyan, Rosa S. Grigoryan & Tigran K. Davtyan
Global Journal of Medical research: B Pharma, Drug Discovery, Toxicology and Medicine Volume 14 Issue 2 Version 1.0 Year 2014